GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Clariane SE (STU:KO2) » Definitions » Capital Expenditure

Clariane SE (STU:KO2) Capital Expenditure : €-363.86 Mil (TTM As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Clariane SE Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Clariane SE's cash flow for capital expenditures for the six months ended in Jun. 2024 was €-156 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2024 was €-363.86 Mil.


Clariane SE Capital Expenditure Historical Data

The historical data trend for Clariane SE's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clariane SE Capital Expenditure Chart

Clariane SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -326.27 -520.10 -528.91 -622.20 -484.11

Clariane SE Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -272.55 -349.65 -276.55 -207.57 -156.30

Clariane SE Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-363.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clariane SE Business Description

Traded in Other Exchanges
Address
21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE operates nursing homes, post-acute and rehabilitation clinics, assisted living facilities, and home care services. Its operating segments are France, Germany, Italy, and Belgium. The majority of its revenue is generated in France. Its nursing homes offer long-term care and medical support for elderly people.

Clariane SE Headlines

No Headlines